©The Author(s) 2026.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 113553
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.113553
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.113553
| miR | Expression | Study model | Target genes | Modulated pathways | Ref. |
| miR-145-5p | Downregulated | In vitro | N-RAS and IRS1 | Cell proliferation by AKT inactivation | Yin et al[152] |
| miR-145-5p | Downregulated | In vitro | CDCA3 | Cell proliferation, migration, invasion, EMT | Chen et al[84] |
| miR-145-5p | Downregulated | In vitro | TWIST1 | Migration and invasion | Shen et al[153] |
| miR-145-5p | Downregulated | In vitro | MAPK1 | Cell proliferation, migration, and invasion | Yang et al[154] |
| miR-145-5p | Downregulated | In vitro | SIP1 | Cell proliferation, migration, and invasion | Sathyanarayanan et al[155] |
| miR-145-5p | Downregulated | In vitro | PAK4 | Migration and invasion | Sheng et al[59] |
| miR-145-5p | Downregulated | In vitro and in vivo | p70S6K1 | Tumor growth and angiogenesis by HIF-1 and VEGF | Xu et al[156] |
| miR-145-5p | Downregulated | In vitro and in vivo | LASP1 | Invasion and metastasis | Wang et al[58] |
| miR-145-5p | Downregulated | In vitro | CXCL1 and ITGA2 | Cell proliferation and migration | Zhuang et al[60] |
| miR-16-5p | Downregulated | In vitro and in vivo | PVT1 | Cell proliferation, migration, and invasion by VEGFA and p-AKT | Rahmati et al[98] |
| miR-16-5p | Downregulated | In vitro and in vivo | ITGA2 | Apoptosis and tumor growth | Xu et al[36] |
| miR-16-5p | Downregulated | In vitro | BIRC5 | Apoptosis, cell proliferation, and angiogenesis | Aslan et al[47] |
| miR-16-5p | Downregulated | In vitro | FOXK1 | Cell proliferation and angiogenesis by PI3K/AKT/mTOR signaling | Huang et al[37] |
| miR-16-5p | Downregulated | In vitro and in vivo | HMGA2 | Migration, invasion, and EMT by β-catenin pathway | Cai et al[63] |
| miR-199a-3p | Downregulated | In vitro | PAK4 and BCAR3 | Cell proliferation, migration and invasion | Hou et al[70] |
| miR-199a-3p | Downregulated | In vitro | FN1 | EMT by N-cadherin and vimentin | Lin et al[71] |
| miR-199a-3p | Downregulated | In vitro | NLK | Metastasis | Han et al[72] |
| miR-199a-3p | Downregulated | In vitro | TGFBR1 and PDGFRB | Cell proliferation by MAPK-signaling | Slattery et al[157] |
| miR-21-3p | Upregulated | In vitro and in vivo | SMAD7 | EMT through the increase of N-cadherin | Jiao et al[39] |
| miR-21-3p | Upregulated | In vitro | RBPMS | Migration, invasion, and apoptosis by Smad4/ERK signaling | Hou et al[53] |
| miR-21-5p | Upregulated | In vitro and in vivo | KRIT1 | Angiogenesis through β-catenin signaling pathway, VEGFA and CCND1 | He et al[31] |
| miR-21-5p | Upregulated | In vitro and in vivo | PDCD4 and TGFBR2 | Stemness promotion by upregulation of β-catenin, c-MYC and cyclin-D1 | Yu et al[158] |
| miR-21-5p | Upregulated | In vitro and in vivo | PTEN | Apoptosis, cell proliferation and invasion | Wu et al[76]; Lin et al[77] |
| miR-21-5p | Upregulated | In vitro and in vivo | CHL1 | Cell proliferation, invasion and tumor growth | Yu et al[79] |
| miR-21-5p | Downregulated | In vitro | TGFBI | Pyroptosis | Jiang et al[82] |
| Downregulated | In vitro | SATB1 | Cells sensitive to chemoradiation | Lopes-Ramos et al[83] | |
| miR-4461 | Downregulated | In vitro | COPB2 | Cell proliferation, migration, and invasion | Chen et al[159] |
| miR-449a | Downregulated | In vitro | HDAC1, TGFB, SATB2, ADAM10, MYC, and MAPK1 | Cell proliferation, invasion and poor survival | Ishikawa et al[160] |
| miR-519d-3p | Downregulated | In vitro | TROAP | Apoptosis, cell proliferation, migration, and invasion | Ye and Lv[161] |
| miRNA-31 | Upregulated | In vitro | STK40 | NF-κB signaling pathway and invasion | Zhu and Xue[162] |
| miR-200a | Upregulated | In vitro | PTEN | Cell proliferation, migration and invasion | Li et al[163] |
| miRNA-552 | Upregulated | In vitro | PTEN | Poor prognosis | Im et al[164] |
| miRNA-552 | Upregulated | In vitro and in vivo | ADAM28 | Cell proliferation, migration and tumor growth | Wang et al[165] |
| miR-592 | Upregulated | In vitro | mTOR and FOXO | Cell proliferation, migration and invasion | Pan et al[166] |
| miR-708 and miR-31 | Upregulated | In vitro | CDKN2B | Cell proliferation, invasion and apoptosis resistance | Lei et al[167] |
| miR-25 | Upregulated | In vitro and in vivo | SIRT6 | Metastasis through inhibited | Wang et al[168] |
| miR-130b-3p | Upregulated | In vitro and in vivo | CHD9 | Cell proliferation and tumor growth | Song et al[169] |
| miRNA-221 | Upregulated | In vitro and in vivo | TP53BP2 | Cell proliferation through TP53 inhibition | Ali et al[124] |
- Citation: Quiroz-Reyes AG, Delgado-Gonzalez P, Islas JF, Loaiza-Gutierrez VL, Santoyo-Suarez MG, Garcia-Loredo JA, Gonzalez-Villarreal CA, Ramirez-Fernandez F, Garza-Treviño EN. Tumor microenvironment-driven microRNA dysregulation: Key interactions in colorectal cancer progression. World J Gastrointest Oncol 2026; 18(1): 113553
- URL: https://www.wjgnet.com/1948-5204/full/v18/i1/113553.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i1.113553